201 related articles for article (PubMed ID: 9733816)
21. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.
Boerkoel CF; Kung HJ
J Virol; 1992 Aug; 66(8):4814-23. PubMed ID: 1321271
[TBL] [Abstract][Full Text] [Related]
22. An RNA secondary structure juxtaposes two remote genetic signals for human T-cell leukemia virus type I RNA 3'-end processing.
Bar-Shira A; Panet A; Honigman A
J Virol; 1991 Oct; 65(10):5165-73. PubMed ID: 1716687
[TBL] [Abstract][Full Text] [Related]
23. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
24. cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1.
Mergia A; Pratt-Lowe E; Shaw KE; Renshaw-Gegg LW; Luciw PA
J Virol; 1992 Jan; 66(1):251-7. PubMed ID: 1309244
[TBL] [Abstract][Full Text] [Related]
25. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.
Hallberg B; Schmidt J; Luz A; Pedersen FS; Grundström T
J Virol; 1991 Aug; 65(8):4177-81. PubMed ID: 1649324
[TBL] [Abstract][Full Text] [Related]
26. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
27. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
28. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
29. Carbon tetrachloride induction of rapid changes in liver nuclear protein factors capable of sequence-specific binding to regulatory elements in the long terminal repeat of polytropic-class endogenous murine leukemia virus-related proviruses.
Hoyt PR; Wang TH; Henley DC; Yang DM; Ch'ang LY; Yang WK
Mol Carcinog; 1993; 8(4):245-54. PubMed ID: 8280373
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells.
Tsukiyama T; Niwa O; Yokoro K
J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663
[TBL] [Abstract][Full Text] [Related]
31. Rat cellular mutants for expression of mRNA from the long terminal repeat of murine retrovirus.
Isaka M; Inoue H; Tsukiyama T; Niwa O; Hakura A
Virology; 1992 Jul; 189(1):141-9. PubMed ID: 1604805
[TBL] [Abstract][Full Text] [Related]
32. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
Ch'ang LY; Yang WK; Myer FE; Yang DM
J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
[TBL] [Abstract][Full Text] [Related]
33. Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.
Van Beveren C; Rands E; Chattopadhyay SK; Lowy DR; Verma IM
J Virol; 1982 Feb; 41(2):542-56. PubMed ID: 6281466
[TBL] [Abstract][Full Text] [Related]
34. RNA polymerase III control elements are required for trans-activation by the murine retroviral long terminal repeat sequences.
Hwang YW; Yoo NK; Yang HM; Choi SY
Biochem Biophys Res Commun; 2015 Jan; 456(1):110-5. PubMed ID: 25446107
[TBL] [Abstract][Full Text] [Related]
35. Tagging the genome of the murine leukemia retrovirus SL3-3 by a bacterial lac operator sequence.
Jørgensen P; Mikkelsen T; Pedersen K; Pedersen FS; Kjeldgaard NO
Gene; 1991 Dec; 109(2):243-7. PubMed ID: 1722473
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
Morrison HL; Dai HY; Pedersen FS; Lenz J
J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
[TBL] [Abstract][Full Text] [Related]
37. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
Faller DV; Weng H; Choi SY
Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
Zaiman AL; Lenz J
J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
[TBL] [Abstract][Full Text] [Related]
39. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
40. Germ line integration of a murine leukemia provirus into a retroviruslike sequence.
Horowitz JM; Holland GD; King SR; Risser R
J Virol; 1987 Mar; 61(3):701-7. PubMed ID: 3027396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
